Safety, Pharmacokinetics, and Pharmacodynamics of SHR7280, a Non-peptide GnRH Antagonist in Premenopausal Women with Endometriosis: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Study

被引：0
|
作者：
Yuan Li
Ying Zheng
Bing Xu
Linrui Cai
Sheng Feng
Yiming Liu
Zhenyi Zhu
Qin Yu
Hongyan Guo
机构：
[1] Peking University Third Hospital,Department of Obstetrics and Gynecology
[2] Sichuan University,Department of Gynecologic Oncology, West China Second University Hospital
[3] Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University),National Drug Clinical Trial Institute, West China Second University Hospital
[4] Ministry of Education,Clinical Research and Development
[5] Sichuan University,undefined
[6] National Drug Clinical Trial Institution of West China Second Hospital,undefined
[7] NMPA Key Laboratory for Technical Resarch on Drug Products In Vitro and In Vivo Correlation,undefined
[8] Jiangsu Hengrui Pharmaceuticals Co.,undefined
[9] Ltd.,undefined
来源：
Clinical Pharmacokinetics | 2023年 / 62卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1739 / 1748
页数：9
相关论文
共 50 条
  • [21] Results of a Double-Blind, Randomized, Placebo-Controlled Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Anti-Zika Virus Immunoglobulin
    White, Jane
    Tunga, Priya
    Anderson, Deborah M.
    Iledan, Ken
    Loreth, Tobi
    Parrera, Geraldine S.
    Astacio, Hugo
    Drobic, Bojan
    Richardson, Jason S.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2021, 105 (06): : 1552 - 1562
  • [22] A randomized, double-blind, placebo-controlled, single-dose study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of denosumab administered subcutaneously to postmenopausal Japanese women
    Kumagai, Yuji
    Hasunuma, Tomoko
    Padhi, Desmond
    BONE, 2011, 49 (05) : 1101 - 1107
  • [23] Human Safety and Pharmacokinetics Study of Orally Administered Icariin: Randomized, Double-Blind, Placebo-Controlled Trial
    Brown, E. Sherwood
    Bice, Collette
    Putnam, William C.
    Leff, Richard
    Kulikova, Alexandra
    Nakamura, Alyson
    Ivleva, Elena I.
    Enkevort, Erin Van
    Holmes, Traci
    Miingi, Nyokabi
    NATURAL PRODUCT COMMUNICATIONS, 2019, 14 (06)
  • [24] A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability and Pharmacodynamics of AMG145
    Dias, Clapton
    Shaywitz, Adam
    Smith, Brian
    Emery, Maurice
    Bing, Gao
    Gibbs, John
    Wishner, Bill
    Stolman, Dina
    Crispino, Caroline
    Crispino, Caroline
    Cook, Blaire
    Colbert, Alex
    Retter, Marc
    Xu, Ren
    Matson, Mark
    CIRCULATION, 2011, 124 (21)
  • [25] Symptomatic treatment of premenstrual mastalgia in premenopausal women with lisuride maleate:: a double-blind placebo-controlled randomized study
    Kaleli, S
    Aydin, Y
    Erel, CT
    Çolgar, U
    FERTILITY AND STERILITY, 2001, 75 (04) : 718 - 723
  • [26] Safety, Tolerability, and Pharmacokinetics of β-Cryptoxanthin Supplementation in Healthy Women: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial
    Tan, Karen M. L.
    Chee, Jolene
    Lim, Kezlyn L. M.
    Ng, Maisie
    Gong, Min
    Xu, Jia
    Tin, Felicia
    Natarajan, Padmapriya
    Lee, Bee Lan
    Ong, Choon Nam
    Tint, Mya Thway
    Kee, Michelle Z. L.
    Muller-Riemenschneider, Falk
    Gluckman, Peter D.
    Meaney, Michael J.
    Kumar, Mukkesh
    Karnani, Neerja
    Eriksson, Johan G.
    Nandanan, Bindu
    Wyss, Adrian
    Cameron-Smith, David
    NUTRIENTS, 2023, 15 (10)
  • [27] Safety, pharmacokinetics and pharmacodynamics of HWH486 capsules in healthy adults: A randomized, double-blind, placebo-controlled, phase I dose-escalation study
    Chen, Man
    Du, Shuangqing
    Cheng, Yue
    Zhu, Xiaohong
    Wang, Ying
    Shu, Shiqing
    Men, Yuchun
    He, Miao
    Wang, Huifang
    He, Zhenyu
    Cai, Ling
    Zhu, Jie
    Wu, Zhe
    Li, Yuqiong
    Feng, Ping
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 126
  • [28] Pharmacokinetics and pharmacodynamics of zolmitriptan in patients with mild to moderate hypertension: A double-blind, placebo-controlled study
    Smith, DA
    Cleary, EW
    Watkins, S
    Huffman, CS
    Dilzer, SC
    Lasseter, KC
    JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 38 (08): : 685 - 693
  • [29] Liraglutide's Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Pediatric Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial
    Klein, David J.
    Battelino, Tadej
    Chatterjee, D. J.
    Jacobsen, Lisbeth V.
    Hale, Paula M.
    Arslanian, Silva
    DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 (10) : 679 - 687
  • [30] THE ALETTA CLINICAL STUDY: DESIGN OF A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY INVESTIGATING THE EFFICACY AND SAFETY OF LYBRIDOTM IN PREMENOPAUSAL WOMEN WITH ACQUIRED FSIAD
    Reisman, Yacov
    Vignozzi, Linda
    Nappi, Rossella
    Giovanni, Corona
    den Hollander, Wil
    van der Mooren, Jan
    Giraldi, Annamaria
    JOURNAL OF SEXUAL MEDICINE, 2023, 20 : 81 - U231
12345